Communicators

Vancouver, British Columbia, July 10, 2019 -- CannaOne Technologies (CNNA: CSE/FSE: 3CT) ("CannaOne" or the "Company") is pleased to announce, the BWell US CBD marketplace went live on June 24, 2019. Not only did the Company succeed to meet an early launch date for the activation of this online marketplace, it received over 11,000 customer sign-ups seeking to gain individual access to purchase from the CBD product offering of 98 US company-based SKU’s. Reward programs were implemented throughout the pre-launch campaign to encourage loyalty and community building, during which time 250 unique winners were awarded various prizes, such as a year’s supply of CBD oils. CannaOne has plans to keep the momentum going by continually running sign-up and awareness initiatives to increase and expand the customer base as the marketplace exponentially grows.

“Our teamwork has been validated by reaching this massive milestone and we’ve proven our strengths in development and marketing. The BWell Market (thebwellmarket.com) has now been launched just months after the Farm Bill passed in the US, which opened up tremendous opportunities to sell and market CBD products. We are truly in on the ground level of this astounding CBD revolution in America and we’re now ready to complete as a dominant player in the online space.”

“The realization of the BWell Market also proves our assumptions going in with an aggressive growth plan. We can develop an enterprise online marketplace, engineer the site for inbound marketing, run a successful pre-launch campaign, stock the shelves with leading global CBD brands and advance our marketing plans all in a few months. The BWell Marketplace encapsulates all of those key components. We now find ourselves in the enviable position to be able to provide a premium turnkey technology solution to CBD product providers that are eager to offer customers around the Globe a full-service marketplace that not only supplies them with products but that educates and engages their community from the ground up. Our team knows we’re only going to get better at this process as we launch more marketplaces in other countries around the world. ”

Specializing

The USA CBD Market:

CBD, a non-psychoactive cannabinoid found in cannabis, has had a surge in popularity over the past couple of years. Unlike THC, the chemical compound that gives marijuana its signature effect, CBD has been shown to help with everything from PTSD and anxiety to MS and epilepsy—without the effects associated with THC.

” In past years CBD products were available mostly in head shops, with a few doctors recommending them for various maladies. But in 2017 and 2018, the products spread rapidly to natural food stores, beauty aisles, cafés and doctors’ offices. It was expected that the industry was on track to hit $591 million in 2018, and thanks to a number of factors—including, surprisingly, Senate Majority Leader Mitch McConnell—that could increase 40 times in the next four years.” - Cannabis Business Times

According to a new estimate from cannabis industry analysts the Brightfield Group, “the hemp-CBD market alone could hit $22 billion by 2022.”

THE BWell Partnership

About Real Health Science

Real Health is a California based company with a focus towards delivering the highest quality CBD products to its customer base covering the California mass market in the most timely and professional services manner possible. In order to accomplish this, Real Health has established working relationships with superior providers in each vertical within our industry; U.S.A. cannabis genetics businesses, U.S.A. cannabis terpene extractors and suppliers, efficient and cost-effective hemp CBD extraction and purification labs in the USA, cGMP manufacturers of finished products, highest rated cannabis testing and certification labs &

supremely effective drop shipping and logistics providers.

About CannaOne Technologies

CannaOne has developed Bloomkit, the first product in the Bloom Product Suite; a turnkey enterprise software solution that can be utilized by any B-to-C cannabis company. Inherent functionalities ensure its users the highest levels of on-going customer satisfaction while the adaptability of Bloomkit, gives clients the ability to operate and satisfy regulatory environments of any governing body around the World, truly affording CannaOne the opportunity to serve an overall base of global clientele with a software suite that sits at the forefront of the industry. The Bloom Product Suite™ is representative of complete data driven and design focused software solutions that contain diverse system architectures and provide intelligent, machine learning that will give clients detailed industry business insights and ultimately lead to the creation and management of predictive content and product recommendation engines.

For further information, please contact:

Solomon Riby-Williams


Chief Executive Officer


solomon@bloomkit.co

604 - 559 - 8893

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDERS HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

FORWARD-LOOKING STATEMENTS: Certain information contained herein may constitute "forward-looking information" under Canadian securities legislation. Generally, forward-looking information can be identified by the use of forward-looking terminology such as, "will be", or variations of such words and phrases or statements that certain actions, events or results "will" occur. Forward-looking statements are based on the Company's estimates and are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of CannaOne to be materially different from those expressed or implied by such forward-looking statements or forward-looking information, including capital expenditures and other costs. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. CannaOne will not update any forward-looking statements or forward-looking information that are incorporated by reference herein, except as required by applicable securities laws.

NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S.A. NEWSWIRES